Riemer, Frank http://orcid.org/0000-0002-3805-5221
Skorve, Ellen
Pasternak, Ofer http://orcid.org/0000-0002-7078-6446
Zaccagna, Fulvio http://orcid.org/0000-0001-6838-9532
Lundervold, Astri J. http://orcid.org/0000-0002-6819-6164
Torkildsen, Øivind
Myhr, Kjell-Morten
Grüner, Renate
Funding for this research was provided by:
Norges Forskningsråd (288164)
Helse Vest
Trond Mohn Foundation: https://mohnfoundation.no/ Dr. Niels Vilhelm Henrichsen and wife Anna Henrichsens Legacy Fund: https://ekstern.filer.uib.no/mofa/okonomi/S%C3%B8knadsskjema Henrichsens legat.pdf
Article History
Received: 12 December 2022
Accepted: 6 June 2023
First Online: 22 June 2023
Competing interests
: The authors declare the following competing interests: Ellen Skorve has received initial funding for this study through an unrestricted research grant from Novartis (project planning and inclusion phase). Øivind Torkildsen has received speaker honoraria from and served on scientific advisory boards for Biogen, Sanofi-Aventis, Merck, and Novartis. Kjell-Morten Myhr has received unrestricted research grants to his institution, scientific advisory board or speaker honoraria from Biogen, Merck, Novartis, Roche, and Sanofi; and has participated in clinical trials organized by Biogen, Merck, Novartis, Roche, and Sanofi. All other authors report no competing interests.